CLDI Calidi Biotherapeutics, Inc.
$0.66▲ +3.13%
Healthcare
Other
Volume 31.3K
Avg Volume (10D) 60.1K
Key Metrics & Fundamentals
Market Cap
$2.43M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.62 - 27.04
% vs 50 MA
-40.48%
% vs 200 MA
-85.94%
RSI-14
20.0
MACD Histogram
-0.0100
Beta (1Y vs SPY)
2.26
Free Cash Flow
-$4.39M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$3.68M
COGS
–
Operating Exp
$4.15M
Operating Income
-$4.15M
EBIT
-$4.15M
Pretax Income
-$4.16M
Net Income
-$4.16M
EPS (Diluted)
-2.94
Price & Volume History
Loading chart…
Recent News
Calidi Biotherapeutics Presented New CLD-401 Data and In Situ TCE Platform Advances at the ESMO Congress 2026, Including Highlighting the Potential of its RedTail Gene Medicine Platform to Turn Tumors into Localized TCE Biofactories
GlobeNewswire · Oct 27, 2026 8:00 AM ET
Calidi Biotherapeutics to Present New CLD-401 Data and In Situ TCE Platform Advances at the ESMO Congress 2026
GlobeNewswire · Oct 19, 2026 8:00 AM ET
Calidi Biotherapeutics Received NYSE American Notification Letter Regarding Stockholders’ Equity Deficiency
GlobeNewswire · Sep 25, 2026 5:00 PM ET
Calidi Biotherapeutics Announces $1.2 Million Registered Direct Offering
GlobeNewswire · Sep 17, 2026 9:10 AM ET
Calidi Biotherapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
GlobeNewswire · Sep 8, 2026 8:00 AM ET
Calidi Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights
GlobeNewswire · Aug 13, 2026 4:30 PM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See CLDI's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.